COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 483: Articles 4821-4830  | Next

Safety, tolerability, and immunogenicity of a new SARS-CoV-2 recombinant Gamma variant RBD-based protein adjuvanted vaccine, used as heterologous booster in healthy adults: a Phase 1 interim report.
Pasquevich, K. A., Coria, L. M., Ceballos, A., Mazzitelli, B., Rodriguez, J. M., Demaria, A., Pueblas Castro, C., Bruno, L., Saposnik, L., Salvatori, M., Varese, A., Gonzalez, S., Gonzalez Martinez, V. V., Geffner, J., Alvarez, D., Laboratorio Pablo Cassara R&D and CMC group for ARVAC-CG, , Feleder, E. C., Halabe, K. E., Perez Lera, P. E., Montes de Oca, F., Vega, J. C., Lombardo, M., Yerino, G. A., Flo, J., Cassataro, J.
10.1101/2023.01.10.22284009 — Posted: 2023-01-11
Inspiration of SARS-CoV-2 envelope protein mutations on pathogenicity of Omicron XBB
Gao, Z.-b., Wang, Y., Ji, H., Zuo, X., Xia, B.
10.1101/2023.01.09.523338 — Posted: 2023-01-10
Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2 strain WA1/2020 as well as variants delta and omicron.
Flamier, A., Bisht, P., Richards, A., Tomasello, D. L., Jaenisch, R.
10.1101/2023.01.10.523422 — Posted: 2023-01-10
HOGVAX: Exploiting Peptide Overlaps to Maximize Population Coverage in Vaccine Design with Application to SARS-CoV-2
Schulte, S. C., Dilthey, A. T., Klau, G. W.
10.1101/2023.01.09.523288 — Posted: 2023-01-10
Analysis of recurrent research pathways for assessing and improving effectiveness in life sciences laboratories
Balas, E. A., Patel, C., Ewing, B., Patel, N., McCoy, T. C., Wise, S., Abdelgawad, Y. H.
10.1101/2023.01.09.23284360 — Posted: 2023-01-10
Unique amino acid substitution in RBD region of SARS-CoV-2 Omicron XAY.2
Salsekar, L., Rahangdale, S., Tamboli, E., Khairnar, K.
10.1101/2023.01.09.523246 — Posted: 2023-01-09
The Ecology of Viruses in Urban Rodents with a Focus on SARS-CoV-2
Fisher, A., Airey, G., Liu, Y., Gemmell, M., Thomas, J., Bentley, E., Whitehead, M., Paxton, W., Pollakis, G., Paterson, S., Viney, M.
10.1101/2023.01.07.523115 — Posted: 2023-01-09
Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants
Jiang, N., Wang, L., Hatta, M., Feng, C., Currier, M., Lin, X., Hossain, J., Cui, D., Mann, B. R., Kovacs, N. A., Wang, W., Atteberry, G., Wilson, M., Chau, R., Lacek, K. A., Paden, C. R., Hassell, N., Rambo-Martin, B., Barnes, J. R., Kondor, R. J., Self, W. H., Rhoads, J. P., Baughman, A., Chappell, J. D., Shapiro, N. I., Gibbs, K. W., Hager, D. N., Lauring, A. S., Surie, D., McMorrow, M. L., Thornburg, N. J., Wentworth, D. E., Zhou, B.
10.1101/2023.01.08.523127 — Posted: 2023-01-09
Effects of Variants of Concern Mutations on the Force-Stability of the SARS-CoV-2:ACE2 Interface and Virus Transmissibility
Bauer, M. S., Gruber, S., Hausch, A., Melo, M. C. R., Gomes, P. S. F. C., Nicolaus, T., Milles, L. F., Bernardi, R. C., Gaub, H. E., Lipfert, J.
10.1101/2023.01.06.522349 — Posted: 2023-01-09
Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern
Frasson, I., Diamante, L., Zangrossi, M., Carbognin, E., Dalla Pieta, A., Penna, A., Rosato, A., Verin, R., Torrigiani, F., Salata, C., Vaccaro, L., Cacchiarelli, D., Richter, S. N., Montagner, M., Martello, G.
10.1101/2023.01.09.523209 — Posted: 2023-01-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).